FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2992575520> ?p ?o ?g. }

• W2992575520 endingPage "840" @default.
• W2992575520 startingPage "829" @default.
• W2992575520 abstract "Arginine (Arg) deprivation is a promising therapeutic approach for tumors with low argininosuccinate synthetase 1 (ASS1) expression. However, its efficacy as a single agent therapy needs to be improved as resistance is frequently observed. Methods: A tissue microarray was performed to assess ASS1 expression in surgical specimens of pancreatic ductal adenocarcinoma (PDAC) and its correlation with disease prognosis. An RNA-Seq analysis examined the role of ASS1 in regulating the global gene transcriptome. A high throughput screen of FDA-approved oncology drugs identified synthetic lethality between histone deacetylase (HDAC) inhibitors and Arg deprivation in PDAC cells with low ASS1 expression. We examined HDAC inhibitor panobinostat (PAN) and Arg deprivation in a panel of human PDAC cell lines, in ASS1-high and -knockdown/knockout isogenic models, in both anchorage-dependent and -independent cultures, and in multicellular complex cultures that model the PDAC tumor microenvironment. We examined the effects of combined Arg deprivation and PAN on DNA damage and the protein levels of key DNA repair enzymes. We also evaluated the efficacy of PAN and ADI-PEG20 (an Arg-degrading agent currently in Phase 2 clinical trials) in xenograft models with ASS1-low and -high PDAC tumors. Results: Low ASS1 protein level is a negative prognostic indicator in PDAC. Arg deprivation in ASS1-deficient PDAC cells upregulated asparagine synthetase (ASNS) which redirected aspartate (Asp) from being used for de novo nucleotide biosynthesis, thus causing nucleotide insufficiency and impairing cell cycle S-phase progression. Comprehensively validated, HDAC inhibitors and Arg deprivation showed synthetic lethality in ASS1-low PDAC cells. Mechanistically, combined Arg deprivation and HDAC inhibition triggered degradation of a key DNA repair enzyme C-terminal-binding protein interacting protein (CtIP), resulting in DNA damage and apoptosis. In addition, S-phase-retained ASS1-low PDAC cells (due to Arg deprivation) were also sensitized to DNA damage, thus yielding effective cell death. Compared to single agents, the combination of PAN and ADI-PEG20 showed better efficacy in suppressing ASS1-low PDAC tumor growth in mouse xenograft models. Conclusion: The combination of PAN and ADI-PEG20 is a rational translational therapeutic strategy for treating ASS1-low PDAC tumors through synergistic induction of DNA damage." @default.
• W2992575520 created "2019-12-13" @default.
• W2992575520 creator A5001373227 @default.
• W2992575520 creator A5014899688 @default.
• W2992575520 creator A5017982913 @default.
• W2992575520 creator A5018755772 @default.
• W2992575520 creator A5026191929 @default.
• W2992575520 creator A5029117087 @default.
• W2992575520 creator A5034539983 @default.
• W2992575520 creator A5042354527 @default.
• W2992575520 creator A5043686209 @default.
• W2992575520 creator A5043782637 @default.
• W2992575520 creator A5056419389 @default.
• W2992575520 creator A5058851560 @default.
• W2992575520 creator A5059419248 @default.
• W2992575520 creator A5066633792 @default.
• W2992575520 creator A5075442335 @default.
• W2992575520 creator A5078484448 @default.
• W2992575520 creator A5086130752 @default.
• W2992575520 creator A5089735037 @default.
• W2992575520 date "2020-01-01" @default.
• W2992575520 modified "2023-10-06" @default.
• W2992575520 title "Histone deacetylase inhibition is synthetically lethal with arginine deprivation in pancreatic cancers with low argininosuccinate synthetase 1 expression" @default.
• W2992575520 cites W1976971569 @default.
• W2992575520 cites W1985780641 @default.
• W2992575520 cites W1992833637 @default.
• W2992575520 cites W2019299732 @default.
• W2992575520 cites W2027449497 @default.
• W2992575520 cites W2031936148 @default.
• W2992575520 cites W2039035649 @default.
• W2992575520 cites W2081173982 @default.
• W2992575520 cites W2093048712 @default.
• W2992575520 cites W2098673687 @default.
• W2992575520 cites W2100035095 @default.
• W2992575520 cites W2106272725 @default.
• W2992575520 cites W2108745454 @default.
• W2992575520 cites W2110195508 @default.
• W2992575520 cites W2112446608 @default.
• W2992575520 cites W2119785831 @default.
• W2992575520 cites W2121055310 @default.
• W2992575520 cites W2129917557 @default.
• W2992575520 cites W2129920232 @default.
• W2992575520 cites W2134972696 @default.
• W2992575520 cites W2135902783 @default.
• W2992575520 cites W2136349400 @default.
• W2992575520 cites W2140814324 @default.
• W2992575520 cites W2145237516 @default.
• W2992575520 cites W2145462268 @default.
• W2992575520 cites W2149142586 @default.
• W2992575520 cites W2165048368 @default.
• W2992575520 cites W2167874373 @default.
• W2992575520 cites W2168992025 @default.
• W2992575520 cites W2296974778 @default.
• W2992575520 cites W2298111168 @default.
• W2992575520 cites W2336072324 @default.
• W2992575520 cites W2342912708 @default.
• W2992575520 cites W2344840591 @default.
• W2992575520 cites W2419128639 @default.
• W2992575520 cites W2516396030 @default.
• W2992575520 cites W2554081000 @default.
• W2992575520 cites W2581037598 @default.
• W2992575520 cites W2586686752 @default.
• W2992575520 cites W2603975891 @default.
• W2992575520 cites W2735063286 @default.
• W2992575520 cites W2743992255 @default.
• W2992575520 cites W2749938176 @default.
• W2992575520 cites W2753622326 @default.
• W2992575520 cites W2756135037 @default.
• W2992575520 cites W2765934351 @default.
• W2992575520 cites W2896968374 @default.
• W2992575520 cites W2898420718 @default.
• W2992575520 cites W2901919444 @default.
• W2992575520 cites W2911188335 @default.
• W2992575520 cites W2922764110 @default.
• W2992575520 cites W2935940369 @default.
• W2992575520 cites W2950983102 @default.
• W2992575520 doi "https://doi.org/10.7150/thno.40195" @default.
• W2992575520 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6929997" @default.
• W2992575520 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31903153" @default.
• W2992575520 hasPublicationYear "2020" @default.
• W2992575520 type Work @default.
• W2992575520 sameAs 2992575520 @default.
• W2992575520 citedByCount "19" @default.
• W2992575520 countsByYear W29925755202020 @default.
• W2992575520 countsByYear W29925755202021 @default.
• W2992575520 countsByYear W29925755202022 @default.
• W2992575520 countsByYear W29925755202023 @default.
• W2992575520 crossrefType "journal-article" @default.
• W2992575520 hasAuthorship W2992575520A5001373227 @default.
• W2992575520 hasAuthorship W2992575520A5014899688 @default.
• W2992575520 hasAuthorship W2992575520A5017982913 @default.
• W2992575520 hasAuthorship W2992575520A5018755772 @default.
• W2992575520 hasAuthorship W2992575520A5026191929 @default.
• W2992575520 hasAuthorship W2992575520A5029117087 @default.
• W2992575520 hasAuthorship W2992575520A5034539983 @default.
• W2992575520 hasAuthorship W2992575520A5042354527 @default.
• W2992575520 hasAuthorship W2992575520A5043686209 @default.
• W2992575520 hasAuthorship W2992575520A5043782637 @default.

• next